Delivering future health solutions.
Health & Life Sciences
Liverpool’s global leadership in health and life sciences is driving innovation in specialist areas such as: Infection; Precision Medicine; Children’s Health; Veterinary Science; Independent Living; and Big Data, Sensors and Internet of Things. With hundreds of medical companies based here, we are part of the Liverpool-Manchester life sciences corridor, which is considered to be one of the UK’s top three clusters of biomedical activity.
At the heart of our life sciences cluster is the Liverpool Knowledge Quarter, which is home to the University of Liverpool, Liverpool John Moores University, Liverpool School of Tropical Medicine and the Royal Liverpool University Hospital. It is fast becoming one of the world’s leading innovation districts and upon completion of its new hospitals, will be one of the largest academic and clinical campuses in the UK.
-
Major European Biomanufacturing cluster -
Highest number of specialist hospitals outside of London -
Home to the world renowned Liverpool School of Tropical Medicine
-
The highest concentration of Category Level 3 laboratories in the UK
There is no better validation of Liverpool City Region’s medical credentials than the global players that choose to locate and reinvest here. From stem cell and gene therapy treatments and nutraceuticals research and development, to large scale manufacturing and the production of pharmaceuticals, vaccines and biologics.
Liverpool City region is home to companies delivering world-class solutions in life sciences from research and trials to medical manufacturing, including AstraZeneca; Allergan; Baxter Healthcare, Bristol Myers Squibb; Lilly; Nestlé Health Science; Seqirus and Unilever. Significant new investments in modern production facilities at these companies have created a vibrant, efficient and cost-competitive environment to produce new drugs and vaccines.
-
The North West is the UK’s third largest life sciences sector by employee numbers -
World class research centres of excellence and facilities -
Life sciences worth in excess of £1.7 billion per annum
The emergence of sensor technologies, big data and robotics is changing the possibilities and processes in the life sciences sector. Liverpool City Region is leading the way with its LCR 4.0 programme, creating a new infrastructure that connects physical and digital assets to make the industrial internet a reality. The Hartree Centre at Sci-Tech Daresbury is shaping the future of digital UK pharmaceutical design, development and manufacturing through big data analytics expertise.
-
Home to Sci-tech Daresbury science & innovation campus -
A UK centre for high-performance computing & big data -
The region's Hartree Centre is transforming UK industry
Get in touch
- +44(0)151 237 3918
- hannah.randles@growthplatform.org
Latest Health & Life Sciences news
-
Liverpool Health Partners announces new Chair
Liverpool Health Partners has today announced the appointment of its new Chair, Professor Eliot Forster. Prof Forster officially took up his post at the Academic Health Science System for Cheshire and Merseyside this month, following the decision by Dr Neil Goodwin CBE to stand down as Chair as part of his move into retirement. Dr […]
-
LIVERPOOL CITY REGION HEALTH & LIFE SCIENCES EVENT – ‘HEALTH & WELL BEING & THE LIVERPOOL PLAN
As we see the UK cautiously starting to return to life outdoors, Liverpool Chamber is bringing some of the leaders in healthcare together to talk about the future.
-
Register to attend the HealthTec Cluster Anniversary Conference – 18 May 2021
The North West HealthTec Cluster was launched in 2019 through a founding partnership between the Science and Technology Facilities Council (STFC), part of UK Research and Innovation, and the North West Coast, Academic Health Sciences Network – The Innovation Agency. Hosted by the National Science and Innovation Campus at Sci-Tech Daresbury, It is a community […]
-
Liverpool ChiroChem Receives £2 million Investment
Liverpool City Region based chemical technology company, Chirochem has announced that it is aiming to rapidly scale up and expand its production capacity to service a growing customer base after securing £2m investment.
-
Liverpool City Region’s NeedleSmart PRO Receives FDA Approval
Liverpool City Region’s award-winning NeedleSmart PRO needle destruction device has achieved FDA approval as a Class II medical device. NeedleSmart Ltd is the FIRST UK company to achieve FDA 510(k) approval (Class II for Sharps Needle Destruction Device (NDD). The innovative NeedleSmart PRO device heats a sharp, contaminated hypodermic needle to 1,300°, then compresses the […]
-
BIOSURFACTANT INNOVATOR HOLIFERM JOINS SCI-TECH DARESBURY AND LAUNCHES PILOT PLANT
Holiferm, the award-winning biotech spin out that specialises in developing environmentally friendly bio-surfactants for use in detergents and toiletries, has launched its new pilot plant in the Techspace One laboratory building at Sci-Tech Daresbury.
-
Sci-Tech Daresbury plans for next phase of development with Project ultraViolet
Sci-Tech Daresbury has further placed itself at the forefront of the UK’s flourishing science and technology sector by announcing their latest development, Project Ultraviolet, with an outline planning application having been submitted to Halton Borough Council.